On Monday, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) opened higher 2.33% from the last session, before settling in for the closing price of $16.33. Price fluctuations for TEVA have ranged from $12.51 to $22.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -0.32%. Company’s average yearly earnings per share was noted 2.39% at the time writing. With a float of $1.15 billion, this company’s outstanding shares have now reached $1.15 billion.
Considering the fact that the conglomerate employs 36167 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 48.77%, operating margin of 8.4%, and the pretax margin is -7.76%.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Teva- Pharmaceutical Industries Ltd. ADR is 0.02%, while institutional ownership is 58.74%. The most recent insider transaction that took place on Mar 05 ’25, was worth 1,128,642. In this transaction Exec. VP, European Commercial of this company sold 70,961 shares at a rate of $15.91, taking the stock ownership to the 48,384 shares. Before that another transaction happened on Mar 04 ’25, when Company’s See “Remarks” sold 15,174 for $15.73, making the entire transaction worth $238,757. This insider now owns 8,077 shares in total.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.52% during the next five years compared to -9.62% drop over the previous five years of trading.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
Check out the current performance indicators for Teva- Pharmaceutical Industries Ltd. ADR (TEVA). In the past quarter, the stock posted a quick ratio of 0.75. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.16. Likewise, its price to free cash flow for the trailing twelve months is 9.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit 0.49 in the next quarter and is forecasted to reach 2.76 in one year’s time.
Technical Analysis of Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
Compared to the last year’s volume of 12.9 million, its volume of 13.68 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 83.03%. Additionally, its Average True Range was 0.68.
During the past 100 days, Teva- Pharmaceutical Industries Ltd. ADR’s (TEVA) raw stochastic average was set at 27.11%, which indicates a significant decrease from 84.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.74% in the past 14 days, which was lower than the 55.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.26, while its 200-day Moving Average is $17.84. Nevertheless, the first resistance level for the watch stands at $16.99 in the near term. At $17.27, the stock is likely to face the second major resistance level. The third major resistance level sits at $17.66. If the price goes on to break the first support level at $16.33, it is likely to go to the next support level at $15.94. Should the price break the second support level, the third support level stands at $15.66.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Key Stats
There are currently 1,133,839K shares outstanding in the company with a market cap of 19.15 billion. Presently, the company’s annual sales total 16,544 M according to its annual income of -1,639 M. Last quarter, the company’s sales amounted to 4,229 M and its income totaled -218,000 K.
